Liquid chromatographic bioanalytical determination of ropivacaine, bupivacaine and major metabolites.
Bioanalytical methods for the determination of ropivacaine, bupivacaine and their major metabolites in urine and blood plasma are presented. Ropivacaine is a new local anaesthetic drug mainly used for surgery and for postoperative pain relief. The samples are hydrolysed and cleaned using solid-phase extraction and analysed using ion-pair reversed-phase liquid chromatography with gradient elution. The analytes are detected using UV at 210 nm. The methods are highly selective and the limits of quantification were 1 microM in urine and 0.1 microM in plasma, respectively. The between-day variance was generally below 3% (RSD).
Astra Pain Control AB, Concept Division, Södertälje, Sweden.
T
T
Arvidsson
Y
Y
Askemark
M M
MM
Halldin
D000577:Amides / Q000097:blood / Q000378:metabolism* / Q000652:urine; D000779:Anesthetics, Local / Q000097:blood / Q000378:metabolism* / Q000652:urine; D000818:Animals; D002045:Bupivacaine / Q000097:blood / Q000378:metabolism* / Q000652:urine; D002138:Calibration; D002853:Chromatography, Liquid / Q000379:methods*; D006801:Humans; D015203:Reproducibility of Results; D000077212:Ropivacaine; D012680:Sensitivity and Specificity; D012756:Sheep; D013056:Spectrophotometry, Ultraviolet
D000577:Amides; D000779:Anesthetics, Local; D000077212:Ropivacaine; D002045:Bupivacaine